Liquidia (LQDA) Income from Non-Controlling Interests (2021 - 2024)
Liquidia's (LQDA) quarterly Income from Non-Controlling Interests came in at $2000.0 in Q3 2024, down 33.33% year-on-year from $3000.0 in Q4 2023, and little changed quarter-over-quarter from $2000.0 in Q2 2024.
Liquidia (LQDA) Income from Non-Controlling Interests (2021 - 2024) Analysis & Trends
Liquidia's Income from Non-Controlling Interests history runs 4 years deep, the most recent figure standing at $2000.0 for Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.46 Bn | 30.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | 395,346.10 |
| 5 | United Therapeutics | 23.13 Bn | 20.98 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn | -12.70 Mn |
| 9 | Elanco Animal Health | 12.60 Bn | 12.18 Bn | 785.00 Mn | - |
| 10 | Liquidia | 7.62 Bn | 7.40 Bn | 121.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | -13,000.00 |
| Sep 30, 2023 | 3,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Mar 31, 2023 | 5,000.00 |
| Dec 31, 2022 | -26,000.00 |
| Sep 30, 2022 | 7,000.00 |
| Jun 30, 2022 | 9,000.00 |
| Mar 31, 2022 | 10,000.00 |
| Dec 31, 2021 | -32,000.00 |
| Sep 30, 2021 | 13,000.00 |
| Jun 30, 2021 | 14,000.00 |